« Back to Record
Twelves, C., Yardley, D., Potter, D. D., Mailliez, A., Moreno-Aspitia, A., Ahn, J. S., Zhao, C., Hoch, U., Tagliaferri, M., Hannah, A. L., Rugo, H., Cortes, J., O'Shaughnessy, J., Awada, A., Perez, E. A., Im, S. A., Gómez-Pardo, P., Schwartzberg, L. L., & Diéras, V. (2017). Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial. European journal of cancer, 76, 205-215. doi:10.1016/j.ejca.2017.02.011
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/253469



